nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—cervical cancer	0.862	1	CbGaD
Lidocaine—ABCB1—Topotecan—cervical cancer	0.0492	0.625	CbGbCtD
Lidocaine—CYP3A4—Topotecan—cervical cancer	0.0295	0.375	CbGbCtD
Lidocaine—EGFR—uterine cervix—cervical cancer	0.00264	0.0558	CbGeAlD
Lidocaine—EGFR—mammalian vulva—cervical cancer	0.00231	0.0488	CbGeAlD
Lidocaine—CYP2C18—uterine cervix—cervical cancer	0.00228	0.0482	CbGeAlD
Lidocaine—EGFR—uterus—cervical cancer	0.0022	0.0465	CbGeAlD
Lidocaine—CYP2C18—mammalian vulva—cervical cancer	0.002	0.0421	CbGeAlD
Lidocaine—SCN4A—renal system—cervical cancer	0.00181	0.0383	CbGeAlD
Lidocaine—EGFR—female gonad—cervical cancer	0.0018	0.038	CbGeAlD
Lidocaine—CYP2C18—vagina—cervical cancer	0.00155	0.0326	CbGeAlD
Lidocaine—SCN3A—decidua—cervical cancer	0.00144	0.0304	CbGeAlD
Lidocaine—SCN3A—renal system—cervical cancer	0.00141	0.0298	CbGeAlD
Lidocaine—SCN2A—vagina—cervical cancer	0.00116	0.0246	CbGeAlD
Lidocaine—EGFR—lymph node—cervical cancer	0.00116	0.0244	CbGeAlD
Lidocaine—SCN3A—female reproductive system—cervical cancer	0.00113	0.0239	CbGeAlD
Lidocaine—SCN3A—vagina—cervical cancer	0.00102	0.0216	CbGeAlD
Lidocaine—CYP2A6—vagina—cervical cancer	0.00102	0.0216	CbGeAlD
Lidocaine—SCN5A—vagina—cervical cancer	0.00102	0.0215	CbGeAlD
Lidocaine—SCN9A—lymph node—cervical cancer	0.000953	0.0201	CbGeAlD
Lidocaine—SLC22A5—uterine cervix—cervical cancer	0.000874	0.0185	CbGeAlD
Lidocaine—SLC22A5—renal system—cervical cancer	0.000818	0.0173	CbGeAlD
Lidocaine—CYP2C8—renal system—cervical cancer	0.000791	0.0167	CbGeAlD
Lidocaine—SLC22A5—endometrium—cervical cancer	0.00079	0.0167	CbGeAlD
Lidocaine—CYP2C8—endometrium—cervical cancer	0.000765	0.0162	CbGeAlD
Lidocaine—CYP3A5—uterine cervix—cervical cancer	0.000764	0.0161	CbGeAlD
Lidocaine—CYP1A2—renal system—cervical cancer	0.000741	0.0156	CbGeAlD
Lidocaine—SCN10A—lymph node—cervical cancer	0.000725	0.0153	CbGeAlD
Lidocaine—CYP3A5—renal system—cervical cancer	0.000714	0.0151	CbGeAlD
Lidocaine—CYP2B6—renal system—cervical cancer	0.00071	0.015	CbGeAlD
Lidocaine—SCN3A—lymph node—cervical cancer	0.000661	0.014	CbGeAlD
Lidocaine—SLC22A5—female reproductive system—cervical cancer	0.000655	0.0138	CbGeAlD
Lidocaine—CYP2C8—female reproductive system—cervical cancer	0.000634	0.0134	CbGeAlD
Lidocaine—SLC22A5—female gonad—cervical cancer	0.000596	0.0126	CbGeAlD
Lidocaine—SLC22A5—vagina—cervical cancer	0.000592	0.0125	CbGeAlD
Lidocaine—CYP2C8—vagina—cervical cancer	0.000573	0.0121	CbGeAlD
Lidocaine—CYP2B6—female reproductive system—cervical cancer	0.000569	0.012	CbGeAlD
Lidocaine—CYP2C9—female reproductive system—cervical cancer	0.000563	0.0119	CbGeAlD
Lidocaine—CYP3A4—renal system—cervical cancer	0.000536	0.0113	CbGeAlD
Lidocaine—CYP2D6—renal system—cervical cancer	0.000528	0.0111	CbGeAlD
Lidocaine—CYP3A5—female gonad—cervical cancer	0.000521	0.011	CbGeAlD
Lidocaine—CYP3A5—vagina—cervical cancer	0.000517	0.0109	CbGeAlD
Lidocaine—CYP2B6—vagina—cervical cancer	0.000514	0.0109	CbGeAlD
Lidocaine—CYP3A4—female reproductive system—cervical cancer	0.000429	0.00907	CbGeAlD
Lidocaine—CYP2D6—female reproductive system—cervical cancer	0.000422	0.00892	CbGeAlD
Lidocaine—ABCB1—epithelium—cervical cancer	0.000409	0.00864	CbGeAlD
Lidocaine—ABCB1—uterine cervix—cervical cancer	0.000406	0.00857	CbGeAlD
Lidocaine—ABCB1—decidua—cervical cancer	0.000386	0.00816	CbGeAlD
Lidocaine—CYP2D6—female gonad—cervical cancer	0.000384	0.00812	CbGeAlD
Lidocaine—SLC22A5—lymph node—cervical cancer	0.000383	0.00809	CbGeAlD
Lidocaine—ABCB1—renal system—cervical cancer	0.000379	0.00802	CbGeAlD
Lidocaine—ABCB1—endometrium—cervical cancer	0.000367	0.00775	CbGeAlD
Lidocaine—ABCB1—mammalian vulva—cervical cancer	0.000355	0.0075	CbGeAlD
Lidocaine—ABCB1—uterus—cervical cancer	0.000338	0.00714	CbGeAlD
Lidocaine—ABCB1—female reproductive system—cervical cancer	0.000304	0.00642	CbGeAlD
Lidocaine—ABCB1—female gonad—cervical cancer	0.000277	0.00584	CbGeAlD
Lidocaine—ABCB1—vagina—cervical cancer	0.000275	0.00581	CbGeAlD
Lidocaine—ABCB1—lymph node—cervical cancer	0.000178	0.00376	CbGeAlD
Lidocaine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000155	0.0124	CbGpPWpGaD
Lidocaine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000145	0.0116	CbGpPWpGaD
Lidocaine—EGFR—Bladder Cancer—FGFR3—cervical cancer	0.000144	0.0115	CbGpPWpGaD
Lidocaine—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—cervical cancer	0.000135	0.0108	CbGpPWpGaD
Lidocaine—EGFR—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000131	0.0105	CbGpPWpGaD
Lidocaine—CYP2A6—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000127	0.0102	CbGpPWpGaD
Lidocaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000123	0.00989	CbGpPWpGaD
Lidocaine—EGFR—E-cadherin signaling in keratinocytes—CTNNB1—cervical cancer	0.000123	0.00983	CbGpPWpGaD
Lidocaine—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000119	0.00952	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000107	0.00857	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—INSM1—cervical cancer	0.000106	0.00852	CbGpPWpGaD
Lidocaine—EGFR—Extracellular vesicle-mediated signaling in recipient cells—MTOR—cervical cancer	0.000104	0.00833	CbGpPWpGaD
Lidocaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	9.53e-05	0.00763	CbGpPWpGaD
Lidocaine—EGFR—Extracellular vesicle-mediated signaling in recipient cells—CTNNB1—cervical cancer	9.23e-05	0.00739	CbGpPWpGaD
Lidocaine—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	9.18e-05	0.00735	CbGpPWpGaD
Lidocaine—EGFR—Gastric Cancer Network 2—CTNNB1—cervical cancer	8.99e-05	0.0072	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Telomerase—TERT—cervical cancer	8.38e-05	0.00671	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	7.7e-05	0.00617	CbGpPWpGaD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—HES1—cervical cancer	7.51e-05	0.00602	CbGpPWpGaD
Lidocaine—SCN9A—L1CAM interactions—EGFR—cervical cancer	7.07e-05	0.00566	CbGpPWpGaD
Lidocaine—EGFR—Stabilization and expansion of the E-cadherin adherens junction—CTNNB1—cervical cancer	7.05e-05	0.00564	CbGpPWpGaD
Lidocaine—EGFR—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—cervical cancer	7.05e-05	0.00564	CbGpPWpGaD
Lidocaine—SCN3A—L1CAM interactions—EGFR—cervical cancer	6.76e-05	0.00541	CbGpPWpGaD
Lidocaine—EGFR—AGE/RAGE pathway—CASP8—cervical cancer	6.73e-05	0.00539	CbGpPWpGaD
Lidocaine—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—cervical cancer	6.57e-05	0.00526	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—MTOR—cervical cancer	6.5e-05	0.00521	CbGpPWpGaD
Lidocaine—SCN4A—L1CAM interactions—EGFR—cervical cancer	6.49e-05	0.0052	CbGpPWpGaD
Lidocaine—SCN2A—L1CAM interactions—EGFR—cervical cancer	6.49e-05	0.0052	CbGpPWpGaD
Lidocaine—EGFR—Signaling events mediated by TCPTP—STAT3—cervical cancer	6.39e-05	0.00512	CbGpPWpGaD
Lidocaine—EGFR—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—cervical cancer	6.37e-05	0.0051	CbGpPWpGaD
Lidocaine—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—cervical cancer	6.34e-05	0.00507	CbGpPWpGaD
Lidocaine—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	6.33e-05	0.00507	CbGpPWpGaD
Lidocaine—SCN10A—L1CAM interactions—EGFR—cervical cancer	6.26e-05	0.00501	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—AKAP13—cervical cancer	6.1e-05	0.00488	CbGpPWpGaD
Lidocaine—EGFR—Bladder Cancer—TP53—cervical cancer	5.98e-05	0.00479	CbGpPWpGaD
Lidocaine—EGFR—Gastric Cancer Network 2—TP53—cervical cancer	5.98e-05	0.00479	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	5.77e-05	0.00462	CbGpPWpGaD
Lidocaine—EGFR—PI-3K cascade—FGFR3—cervical cancer	5.74e-05	0.00459	CbGpPWpGaD
Lidocaine—EGFR—PI3K/AKT activation—FGFR3—cervical cancer	5.6e-05	0.00449	CbGpPWpGaD
Lidocaine—EGFR—GAB1 signalosome—FGFR3—cervical cancer	5.56e-05	0.00445	CbGpPWpGaD
Lidocaine—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—cervical cancer	5.43e-05	0.00435	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Telomerase—MTOR—cervical cancer	5.41e-05	0.00433	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	5.27e-05	0.00422	CbGpPWpGaD
Lidocaine—EGFR—LPA receptor mediated events—CASP3—cervical cancer	5.22e-05	0.00418	CbGpPWpGaD
Lidocaine—EGFR—Signaling events mediated by PTP1B—STAT3—cervical cancer	5.18e-05	0.00415	CbGpPWpGaD
Lidocaine—EGFR—AGE/RAGE pathway—CASP3—cervical cancer	5.09e-05	0.00408	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	4.85e-05	0.00388	CbGpPWpGaD
Lidocaine—CYP2A6—Fluoropyrimidine Activity—TP53—cervical cancer	4.82e-05	0.00386	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—HES1—cervical cancer	4.8e-05	0.00384	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—HES1—cervical cancer	4.59e-05	0.00367	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	4.51e-05	0.00361	CbGpPWpGaD
Lidocaine—EGFR—Constitutive PI3K/AKT Signaling in Cancer—MTOR—cervical cancer	4.48e-05	0.00359	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—HES1—cervical cancer	4.41e-05	0.00353	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—HES1—cervical cancer	4.41e-05	0.00353	CbGpPWpGaD
Lidocaine—SCN5A—L1CAM interactions—EGFR—cervical cancer	4.4e-05	0.00353	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	4.33e-05	0.00347	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—FGFR3—cervical cancer	4.29e-05	0.00343	CbGpPWpGaD
Lidocaine—EGFR—AGE/RAGE pathway—STAT3—cervical cancer	4.28e-05	0.00343	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—HES1—cervical cancer	4.25e-05	0.0034	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	4.23e-05	0.00339	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—FGFR3—cervical cancer	4.1e-05	0.00329	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	4.1e-05	0.00329	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—FGFR3—cervical cancer	4.04e-05	0.00323	CbGpPWpGaD
Lidocaine—EGFR—PI-3K cascade—MTOR—cervical cancer	4.04e-05	0.00323	CbGpPWpGaD
Lidocaine—EGFR—PI3K/AKT activation—MTOR—cervical cancer	3.94e-05	0.00316	CbGpPWpGaD
Lidocaine—EGFR—GAB1 signalosome—MTOR—cervical cancer	3.91e-05	0.00313	CbGpPWpGaD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—cervical cancer	3.91e-05	0.00313	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	3.89e-05	0.00311	CbGpPWpGaD
Lidocaine—EGFR—Androgen receptor signaling pathway—CTNNB1—cervical cancer	3.87e-05	0.0031	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—FGFR3—cervical cancer	3.86e-05	0.00309	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—FGFR3—cervical cancer	3.84e-05	0.00307	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—TP53—cervical cancer	3.84e-05	0.00307	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—MTOR—cervical cancer	3.82e-05	0.00306	CbGpPWpGaD
Lidocaine—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—MTOR—cervical cancer	3.82e-05	0.00306	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—FGFR3—cervical cancer	3.82e-05	0.00306	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—FGFR3—cervical cancer	3.8e-05	0.00304	CbGpPWpGaD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	3.77e-05	0.00302	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—UBE3A—cervical cancer	3.75e-05	0.003	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cervical cancer	3.75e-05	0.003	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—NOTCH1—cervical cancer	3.62e-05	0.0029	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—FGFR3—cervical cancer	3.58e-05	0.00286	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—FGFR3—cervical cancer	3.58e-05	0.00286	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—FGFR3—cervical cancer	3.58e-05	0.00286	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—FGFR3—cervical cancer	3.54e-05	0.00284	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—FGFR3—cervical cancer	3.51e-05	0.00281	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—FGFR3—cervical cancer	3.5e-05	0.0028	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	3.47e-05	0.00278	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—NOTCH1—cervical cancer	3.46e-05	0.00277	CbGpPWpGaD
Lidocaine—EGFR—Androgen receptor signaling pathway—STAT3—cervical cancer	3.37e-05	0.0027	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—NOTCH1—cervical cancer	3.33e-05	0.00266	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—NOTCH1—cervical cancer	3.33e-05	0.00266	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—FGFR3—cervical cancer	3.31e-05	0.00265	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—TAAR6—cervical cancer	3.24e-05	0.00259	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	3.23e-05	0.00258	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—NOTCH1—cervical cancer	3.21e-05	0.00257	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—CASP3—cervical cancer	3.2e-05	0.00256	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—CASP8—cervical cancer	3.19e-05	0.00255	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	3.17e-05	0.00254	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—MTOR—cervical cancer	3.02e-05	0.00242	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HES1—cervical cancer	2.99e-05	0.00239	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—STAT3—cervical cancer	2.95e-05	0.00236	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—CASP8—cervical cancer	2.94e-05	0.00236	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—MTOR—cervical cancer	2.89e-05	0.00231	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	2.88e-05	0.0023	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	2.86e-05	0.00229	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—MTOR—cervical cancer	2.84e-05	0.00228	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—TP53—cervical cancer	2.75e-05	0.0022	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—MTOR—cervical cancer	2.71e-05	0.00217	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—MTOR—cervical cancer	2.7e-05	0.00216	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	2.7e-05	0.00216	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—MTOR—cervical cancer	2.69e-05	0.00215	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—MTOR—cervical cancer	2.67e-05	0.00214	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—EGFR—cervical cancer	2.67e-05	0.00214	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	2.64e-05	0.00211	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	2.63e-05	0.0021	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—EGFR—cervical cancer	2.55e-05	0.00205	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	2.53e-05	0.00203	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—WNT2—cervical cancer	2.53e-05	0.00202	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—MTOR—cervical cancer	2.52e-05	0.00201	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	2.52e-05	0.00201	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—MTOR—cervical cancer	2.52e-05	0.00201	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—MTOR—cervical cancer	2.49e-05	0.002	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—MTOR—cervical cancer	2.47e-05	0.00198	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—MTOR—cervical cancer	2.46e-05	0.00197	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—EGFR—cervical cancer	2.45e-05	0.00197	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—EGFR—cervical cancer	2.45e-05	0.00197	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—FGFR3—cervical cancer	2.44e-05	0.00195	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—CASP3—cervical cancer	2.41e-05	0.00193	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—CTNNB1—cervical cancer	2.41e-05	0.00193	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—EGFR—cervical cancer	2.37e-05	0.00189	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CA9—cervical cancer	2.35e-05	0.00188	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—STAT3—cervical cancer	2.33e-05	0.00187	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—MTOR—cervical cancer	2.33e-05	0.00186	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—CTNNB1—cervical cancer	2.3e-05	0.00184	CbGpPWpGaD
Lidocaine—EGFR—Immune System—UBE3A—cervical cancer	2.27e-05	0.00182	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—NOTCH1—cervical cancer	2.26e-05	0.00181	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HLA-DPB1—cervical cancer	2.24e-05	0.00179	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	2.23e-05	0.00178	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—CASP3—cervical cancer	2.23e-05	0.00178	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKAP13—cervical cancer	2.22e-05	0.00178	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—CTNNB1—cervical cancer	2.21e-05	0.00177	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—CTNNB1—cervical cancer	2.21e-05	0.00177	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	2.18e-05	0.00174	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—CTNNB1—cervical cancer	2.13e-05	0.00171	CbGpPWpGaD
Lidocaine—EGFR—Disease—WNT2—cervical cancer	2.13e-05	0.00171	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—CTNNB1—cervical cancer	2.11e-05	0.00169	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	2.1e-05	0.00168	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—STAT3—cervical cancer	2.1e-05	0.00168	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—STAT3—cervical cancer	2.1e-05	0.00168	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	2.09e-05	0.00168	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	2.09e-05	0.00168	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	2.09e-05	0.00167	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TP53—cervical cancer	2.05e-05	0.00164	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—STAT3—cervical cancer	2.01e-05	0.00161	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HES1—cervical cancer	1.96e-05	0.00157	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—STAT3—cervical cancer	1.94e-05	0.00156	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—STAT3—cervical cancer	1.93e-05	0.00154	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—STAT3—cervical cancer	1.93e-05	0.00154	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—WNT5A—cervical cancer	1.91e-05	0.00153	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TAAR6—cervical cancer	1.91e-05	0.00153	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—EGFR—cervical cancer	1.91e-05	0.00153	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—STAT3—cervical cancer	1.9e-05	0.00152	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—STAT3—cervical cancer	1.86e-05	0.00149	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—EGFR—cervical cancer	1.82e-05	0.00146	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—cervical cancer	1.79e-05	0.00143	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—EGFR—cervical cancer	1.75e-05	0.0014	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—EGFR—cervical cancer	1.75e-05	0.0014	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HLA-DQB1—cervical cancer	1.75e-05	0.0014	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	1.72e-05	0.00138	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—MTOR—cervical cancer	1.71e-05	0.00137	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—EGFR—cervical cancer	1.69e-05	0.00135	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—cervical cancer	1.68e-05	0.00135	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—EGFR—cervical cancer	1.66e-05	0.00133	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD8A—cervical cancer	1.63e-05	0.00131	CbGpPWpGaD
Lidocaine—EGFR—Disease—WNT5A—cervical cancer	1.61e-05	0.00129	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—CASP3—cervical cancer	1.58e-05	0.00126	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CA9—cervical cancer	1.56e-05	0.00125	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—cervical cancer	1.55e-05	0.00124	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—CTNNB1—cervical cancer	1.5e-05	0.0012	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—WNT2—cervical cancer	1.49e-05	0.00119	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NOTCH1—cervical cancer	1.48e-05	0.00118	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.45e-05	0.00116	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CA9—cervical cancer	1.43e-05	0.00114	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	1.4e-05	0.00112	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—FGFR3—cervical cancer	1.39e-05	0.00111	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HLA-DPB1—cervical cancer	1.36e-05	0.00109	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—FGFR3—cervical cancer	1.33e-05	0.00107	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—STAT3—cervical cancer	1.32e-05	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKAP13—cervical cancer	1.31e-05	0.00105	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—STAT3—cervical cancer	1.31e-05	0.00105	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CASP8—cervical cancer	1.19e-05	0.000951	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—cervical cancer	1.19e-05	0.000951	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CA9—cervical cancer	1.15e-05	0.000923	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—WNT5A—cervical cancer	1.13e-05	0.000905	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CA9—cervical cancer	1.13e-05	0.000902	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.1e-05	0.00088	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HLA-DQB1—cervical cancer	1.06e-05	0.000848	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.06e-05	0.000848	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD8A—cervical cancer	9.89e-06	0.000792	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CTNNB1—cervical cancer	9.81e-06	0.000786	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—MTOR—cervical cancer	9.77e-06	0.000783	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CA9—cervical cancer	9.76e-06	0.000782	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CD4—cervical cancer	9.76e-06	0.000781	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—MTHFR—cervical cancer	9.52e-06	0.000762	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—MTOR—cervical cancer	9.39e-06	0.000752	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD4—cervical cancer	9.37e-06	0.00075	CbGpPWpGaD
Lidocaine—EGFR—Disease—HES1—cervical cancer	9.29e-06	0.000744	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CTNNB1—cervical cancer	8.67e-06	0.000694	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—STAT3—cervical cancer	8.55e-06	0.000685	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CA9—cervical cancer	8.51e-06	0.000681	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	8.39e-06	0.000672	CbGpPWpGaD
Lidocaine—EGFR—Disease—MTHFR—cervical cancer	8.16e-06	0.000654	CbGpPWpGaD
Lidocaine—EGFR—Disease—TERT—cervical cancer	8.14e-06	0.000652	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FGFR3—cervical cancer	8.09e-06	0.000648	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CA9—cervical cancer	8.01e-06	0.000642	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CA9—cervical cancer	7.95e-06	0.000636	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOTCH2—cervical cancer	7.94e-06	0.000635	CbGpPWpGaD
Lidocaine—EGFR—Disease—FGFR3—cervical cancer	7.47e-06	0.000598	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	7.05e-06	0.000564	CbGpPWpGaD
Lidocaine—EGFR—Disease—NOTCH1—cervical cancer	7.01e-06	0.000562	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CASP8—cervical cancer	6.92e-06	0.000554	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CA9—cervical cancer	6.79e-06	0.000544	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HES1—cervical cancer	6.51e-06	0.000521	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—MTHFR—cervical cancer	6.33e-06	0.000507	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—MTHFR—cervical cancer	5.8e-06	0.000464	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TERT—cervical cancer	5.7e-06	0.000456	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MTOR—cervical cancer	5.69e-06	0.000456	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD4—cervical cancer	5.68e-06	0.000455	CbGpPWpGaD
Lidocaine—EGFR—Disease—MTOR—cervical cancer	5.26e-06	0.000421	CbGpPWpGaD
Lidocaine—EGFR—Disease—CD4—cervical cancer	5.25e-06	0.00042	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CA9—cervical cancer	5.24e-06	0.00042	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGFR3—cervical cancer	5.23e-06	0.000419	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTNNB1—cervical cancer	5.05e-06	0.000404	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOTCH1—cervical cancer	4.91e-06	0.000393	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—MTHFR—cervical cancer	4.68e-06	0.000375	CbGpPWpGaD
Lidocaine—EGFR—Disease—CTNNB1—cervical cancer	4.66e-06	0.000373	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—MTHFR—cervical cancer	4.57e-06	0.000366	CbGpPWpGaD
Lidocaine—EGFR—Immune System—STAT3—cervical cancer	4.4e-06	0.000352	CbGpPWpGaD
Lidocaine—EGFR—Disease—STAT3—cervical cancer	4.06e-06	0.000325	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MTHFR—cervical cancer	3.96e-06	0.000317	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MTOR—cervical cancer	3.68e-06	0.000295	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MTHFR—cervical cancer	3.45e-06	0.000276	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—cervical cancer	3.39e-06	0.000271	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CTNNB1—cervical cancer	3.26e-06	0.000261	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MTHFR—cervical cancer	3.25e-06	0.00026	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MTHFR—cervical cancer	3.22e-06	0.000258	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STAT3—cervical cancer	2.84e-06	0.000228	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MTHFR—cervical cancer	2.76e-06	0.000221	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—cervical cancer	2.17e-06	0.000174	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTHFR—cervical cancer	2.13e-06	0.00017	CbGpPWpGaD
